Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07472062

Development of a Non-Invasive Prognostic Test for Graves Orbitopathy

The aim of this research project is to develop a non-invasive, simple, robust, and sensitive prognostic test that can identify hyperthyroidism patients who are at risk of developing Graves' Orbitopathy. This phase of the study is a research phase in which we analyze blood samples and tear fluid using standard laboratory equipment and software. The aim is to identify biomarkers that can detect patients at risk of developing Graves' Orbitopathy. Offering more personalized advice, treatment, and follow-up could potentially prevent the clinical consequences or limit their severity.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy control OR diagnosis of hyperthyroidism OR diagnosis of Graves' Orbitopathy

Exclusion criteria

  • <18 y/o

Treatment and study plan

Schirmer's test

Other

Collection of tears with Schirmer's test

Primary outcomes

  1. Biomarkers found in tears collected at Baseline

    Time frame: Baseline

    During a one-day study visit (Baseline visit), tears will be collected from all study participants via a Schirmer's test.

Sponsors and collaborators

Lead sponsor

University Hospital, Ghent

Other

Registry information

Acronym: GoPro

Important dates

Study start
2023
Primary completion
2024
Study completion
2026
First posted
Mar 16, 2026
Registry last updated
Mar 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.